 Life Science Events, Jobs, Directory, News  SAN DIEGO–(BUSINESS WIRE)– #AACR2026–Voro Therapeutics, a biotechnology company pioneering tumor-activated biologics to improve the safety and efficacy of cancer therapies, today announced upcoming oral presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026 and the Antibody Engineering & Therapeutics (AET) Europe conference. Voro Therapeutics will present new preclinical data showcasing the power of its proprietary PrimeBody biologics platform and the broad therapeu
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative. |